protein

Galectin-9/LGALS9 Protein, Human (HEK293, hFc)

HY-P75176

10 μg;50 μg;100 μg

75;200;340 USD

Galectin-9/LGALS9 Protein, Human (HEK293, hFc)

proteins

HEK293

10 μg;50 μg;100 μg

75;200;340 USD

Galectin-9/LGALS9 Protein acts as an eosinophil chemoattractant, recruiting and migrating eosinophils, key immune cells in inflammatory responses. It also serves as an angiogenesis inhibitor, regulating blood vessel formation and impacting vascular processes. Functioning as a regulatory modulator, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways. Galectin-9/LGALS9 Protein, Human (HEK293, hFc) is the recombinant human-derived Galectin-9/LGALS9 protein, expressed by HEK293 , with N-hFc labeled tag. The total length of Galectin-9/LGALS9 Protein, Human (HEK293, hFc) is 322 a.a., with molecular weight of ~64.8 kDa.

Human

Galectin-9/LGALS9 protein functions as an eosinophil chemoattractant, actively participating in the recruitment and migration of eosinophils, crucial immune cells involved in inflammatory responses. Moreover, it serves as an angiogenesis inhibitor, contributing to the regulation of blood vessel formation and impacting vascular processes. In its role as a regulatory modulator of immune responses, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways (By similarity).

Galectin-9; Gal-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9

Greater than 90% as determined by reducing SDS-PAGE.

Supplied as a 0.2 μm filtered solution of PBS, pH 7.4.

Shipping with dry ice